WFL fundamentals
WELLFULLY LIMITED revenue breakdown overview
By source
2017
2018
2019
2020
2021
2022
2023
2024
0.00
600.00 K
1.20 M
1.80 M
2.40 M
Devices
Dermaportation and Drug Delivery Technology
Royalties
Research and Development Collaboration Revenue and Tax Incentives
Interest Received
Currency: AUD
2017
2018
2019
2020
2021
2022
2023
2024
Devices
—
240.00 K
1.85 M
1.02 M
—
Dermaportation and Drug Delivery Technology
570.55 K
222.98 K
250.36 K
482.32 K
—
Royalties
—
—
—
—
—
Research and Development Collaboration Revenue and Tax Incentives
—
—
—
—
—
Interest Received
—
—
—
—
—
By country
2017
2018
2019
2020
2021
2022
2023
2024
0.00
600.00 K
1.20 M
1.80 M
2.40 M
Europe
United States
Singapore
Japan
Australia
Currency: AUD
2017
2018
2019
2020
2021
2022
2023
2024
Europe
—
240.01 K
1.86 M
1.51 M
—
United States
—
—
238.23 K
—
—
Singapore
570.55 K
222.97 K
—
—
—
Japan
—
—
—
—
—
Australia
—
—
—
—
—